The medicinal plants for Covid-19 treatments
-
Published:2022-12-01
Issue:12
Volume:10
Page:250-259
-
ISSN:2411-2933
-
Container-title:International Journal for Innovation Education and Research
-
language:
-
Short-container-title:Int J Innov Educ Res
Author:
Vieitas DiurienyORCID, Neto Moacir Monteiro, Silva Valéria, Santos Janaina, Da silva Silvana, Amaral Raquel, Dos Santos Thais
Abstract
It’s well know that the use of medicinal plants for treatment of diseases are tradicional practice and sterted at the beginning of medicine and the knowledge the went through generation to generation. Goal: Analyze studies about the use of medicinal palnts to treatment and prevantion for COVID-19 inside the national and internacional scientific journals in the last three years. Method: It’s an integrative literature review which analyzed the quantitatives data. The Virtual Library Health was used for research during the months of Octuber to November. Results:About the mean question was found just fews studies that could answer this research goals, 8 (0,65%) researchs show that the use of medicinal palnts need be more explore for achieved a better understament. Coclusion: the data collect show that some plants like Turmeric working a positive way for treating symptoms of COVID-19, also was found another kinds of plants, we have the exemplo of the maoto as a pre-exposure treatment measure for the virus. So medicinal plants have the potential to be used as a treatment for COVID-19 but we need more research about the properties of these plants.
Publisher
International Journal for Innovation Education and Research
Reference14 articles.
1. Askari, G., Sahebkar, A., Soleimani, D., Mahdavi, A., Rafiee, S., Majeed, M., Khorvash, F., Iraj, B., Elyasi, M., Rouhani, M. H., & Bagherniya, M. (2022). The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial. Trials, 23(1). https://doi.org/10.1186/s13063-022-06375-w 2. Brasil. Ministério da Saúde. (2015). Política Nacional de Práticas Integrativas e Complementares no SUS. Ministério da Saúde: 2015. 3. Gardin, N. E., & Braga, A. J. (2021). Greater celandine (Chelidonium majus L.) for COVID ‐19: A twenty‐case series. Phytotherapy Research, 35(7), 3792–3798. https://doi.org/10.1002/ptr.7085 4. Hassaniazad, M., Eftekhar, E., Inchehsablagh, B. R., Kamali, H., Tousi, A., Jaafari, M. R., Rafat, M., Fathalipour, M., Nikoofal‐Sahlabadi, S., Gouklani, H., Alizade, H., & Nikpoor, A. R. (2021). A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID ‐19 patients. Phytotherapy Research, 35(11), 6417–6427. https://doi.org/10.1002/ptr.7294 5. Hassaniazad, M., Eftekhar, E., Inchehsablagh, B. R., Kamali, H., Tousi, A., Jaafari, M. R., Rafat, M., Fathalipour, M., Nikoofal‐Sahlabadi, S., Gouklani, H., Alizade, H., & Nikpoor, A. R. (2021). A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID ‐19 patients. Phytotherapy Research, 35(11), 6417–6427. https://doi.org/10.1002/ptr.7294
|
|